wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26866922-284A778D-5A4E-4F8A-BA7E-4130518BEE3B
Q26866922-284A778D-5A4E-4F8A-BA7E-4130518BEE3B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26866922-284A778D-5A4E-4F8A-BA7E-4130518BEE3B
Hematopoietic growth factors: personalization of risks and benefits
P2860
Q26866922-284A778D-5A4E-4F8A-BA7E-4130518BEE3B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26866922-284A778D-5A4E-4F8A-BA7E-4130518BEE3B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ab6acc2e222a3ecc808e6d4a014936b5e7fd68b4
P2860
First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study.